2.21
price up icon0.91%   +0.02
pre-market  Pre-market:  2.28   0.07   +3.17%
loading
Accuray Inc stock is currently priced at $2.21, with a 24-hour trading volume of 683.35K. It has seen a +0.91% increased in the last 24 hours and a -14.01% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $2.20 pivot point. If it approaches the $2.24 resistance level, significant changes may occur.

Accuray Inc Stock (ARAY) Financials Data

Accuray Inc (ARAY) Revenue 2024

ARAY reported a revenue (TTM) of $447.48 million for the quarter ending December 31, 2023, a +7.20% rise year-over-year.
loading

Accuray Inc (ARAY) Net Income 2024

ARAY net income (TTM) was -$14.55 million for the quarter ending December 31, 2023, a -23.06% decrease year-over-year.
loading

Accuray Inc (ARAY) Cash Flow 2024

ARAY recorded a free cash flow (TTM) of $7.61 million for the quarter ending December 31, 2023, a +115.32% increase year-over-year.
loading

Accuray Inc (ARAY) Earnings per Share 2024

ARAY earnings per share (TTM) was -$0.15 for the quarter ending December 31, 2023, a -15.38% decline year-over-year.
loading

Accuray Inc Stock (ARAY) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Corradetti GIna
VP, CAO and Controller
Jan 03 '24
Sale
2.74
14,129
38,729
196,138
Pervaiz Ali
SVP Chief Financial Officer
Jan 03 '24
Sale
2.74
2,116
5,800
402,743
Winter Suzanne C
President
Dec 01 '23
Sale
2.47
65,390
161,624
1,369,811
Chew Jesse
SVP, General Counsel
Dec 01 '23
Sale
2.47
29,770
73,565
381,920
Hoge Michael
Senior VP Global Operations
Dec 01 '23
Sale
2.47
19,212
47,482
402,199
Spine Patrick
SVP, Chief Admin Officer
Dec 01 '23
Sale
2.47
14,832
36,653
219,484
Chalke Sandeep
SVP, Chief Commercial Officer
Dec 01 '23
Sale
2.47
14,585
36,041
555,640
Pervaiz Ali
SVP Chief Financial Officer
Dec 01 '23
Sale
2.47
13,463
33,271
404,859
Winter Suzanne C
President
Nov 01 '23
Sale
2.57
38,338
98,529
1,436,616
Pervaiz Ali
SVP Chief Financial Officer
Oct 31 '23
Sale
2.58
3,303
8,534
401,857
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. The company markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors and sales agents in Europe, Japan and other countries of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
medical_devices PHG
$19.98
price down icon 0.84%
medical_devices STE
$200.81
price up icon 0.28%
$301.34
price up icon 0.40%
medical_devices ZBH
$119.33
price down icon 1.62%
$134.30
price up icon 0.33%
medical_devices EW
$86.45
price down icon 0.91%
Cap:     |  Volume (24h):